Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America

Conclusions. The observed vaccine efficacy against asymptomatic dengue virus infections is expected to translate into reduced dengue virus transmission if sufficient individuals are vaccinated in dengue-endemic areas.

Source: The Journal of Infectious Diseases - September 12, 2016 Category: Infectious Diseases Authors: Olivera-Botello, G., Coudeville, L., Fanouillere, K., Guy, B., Chambonneau, L., Noriega, F., Jackson, N., for the CYD-TDV Vaccine Trial Group, Arredondo-Garcia, Bouckenooghe, Capeding, Chotpitayasunondh, Chua, Supelano, Deseda, Dietze, Frago, Hadinegoro, Tags: VIRUSES Source Type: research